Xiao-Ping Chen (Xiaoping Chen)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Transforming Growth Factor

Cancer Stem Cells

Histone Deacetylase

Top Venues

Cell death discovery

Cell death & disease

JMIR formative research

Cell death and differentiation

This page only lists publications with an associated author ORCID identifier.

Publications

Junqing Jiang, Yufei Wang, Mengyu Sun, Xiangyuan Luo, Zerui Zhang, Yijun Wang, Siwen Li, Dian Hu, Jiaqian Zhang, Zhangfan Wu, Xiao-Ping Chen, Bixiang Zhang, Xiao Xu, Shuai Wang, Shengjun Xu, Wenjie Huang, Limin Xia
SOX on tumors, a comfort or a constraint? Cell death discovery 10 (1) (2024)
Lei Xu, Qiumeng Liu, Hailing Liu, Feimu Fan, Pengcheng Li, Shiwei Yue, Jie Mo, Zhicheng Liu, Renshun Dong, Xuewu Zhang, Hanhua Dong, Hui-Fang Liang, Xiao-Ping Chen, Bixiang Zhang, Lin Chen, Jin Chen
Disrupting CCDC137-mediated LZTS2 and β-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via β-catenin and AKT. Cell death and differentiation (2024)
Junqing Jiang, Yufei Wang, Mengyu Sun, Xiangyuan Luo, Zerui Zhang, Yijun Wang, Siwen Li, Dian Hu, Jiaqian Zhang, Zhangfan Wu, Xiao-Ping Chen, Bixiang Zhang, Xiao Xu, Shuai Wang, Shengjun Xu, Wenjie Huang, Limin Xia
SOX on tumors, a comfort or a constraint? Cell death discovery 10 (1) (2024)
Junqing Jiang, Yufei Wang, Mengyu Sun, Xiangyuan Luo, Zerui Zhang, Yijun Wang, Siwen Li, Dian Hu, Jiaqian Zhang, Zhangfan Wu, Xiao-Ping Chen, Bixiang Zhang, Xiao Xu, Shuai Wang, Shengjun Xu, Wenjie Huang, Limin Xia
SOX on tumors, a comfort or a constraint? Cell death discovery 10 (1) (2024)
Junqing Jiang, Yufei Wang, Mengyu Sun, Xiangyuan Luo, Zerui Zhang, Yijun Wang, Siwen Li, Dian Hu, Jiaqian Zhang, Zhangfan Wu, Xiao-Ping Chen, Bixiang Zhang, Xiao Xu, Shuai Wang, Shengjun Xu, Wenjie Huang, Limin Xia
SOX on tumors, a comfort or a constraint? Cell death discovery 10 (1) (2024)
Chang Shu, Yueyue Chen, Huiyuan Yang, Ran Tao, Xiao-Ping Chen, Jingjing Yu
Investigation and Countermeasures Research of Hospital Information Construction of Tertiary Class-A Public Hospitals in China: Questionnaire Study. JMIR formative research 7 (2023)
Chang Shu, Yueyue Chen, Huiyuan Yang, Ran Tao, Xiao-Ping Chen, Jingjing Yu
Investigation and Countermeasures Research of Hospital Information Construction of Tertiary Class-A Public Hospitals in China: Questionnaire Study. JMIR formative research 7 (2023)
Chang Shu, Yueyue Chen, Huiyuan Yang, Ran Tao, Xiao-Ping Chen, Jingjing Yu
Investigation and Countermeasures Research of Hospital Information Construction of Tertiary Class-A Public Hospitals in China: Questionnaire Study. JMIR formative research 7 (2023)
Chang Shu, Yueyue Chen, Huiyuan Yang, Ran Tao, Xiao-Ping Chen, Jingjing Yu
Investigation and Countermeasures Research of Hospital Information Construction of Tertiary Class-A Public Hospitals in China: Questionnaire Study. JMIR formative research 7 (2023)
Xiaoqiong Zhang, Zhaohan Wei, Tu-Ying Yong, Shiyu Li, Nana Bie, Jianye Li, Xin Li, Haojie Liu, Hang Xu, Yuchen Yan, Bixiang Zhang, Xiao-Ping Chen, Xiangliang Yang, Lu Gan
Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8 + T cells to boost anti-PD-1 therapy. Nature communications 14 (1) (2023)
Qibo Huang, Jie Mo, Zhibin Liao, Xiao-Ping Chen, Bixiang Zhang
The RNA m 6 A writer WTAP in diseases: structure, roles, and mechanisms. Cell death & disease 13 (10) (2022)
Hongwei Zhang, Yachong Liu, Wei Wang, Furong Liu, Weijian Wang, Chen Su, He Zhu, Zhibin Liao, Bixiang Zhang, Xiao-Ping Chen
ALKBH5-mediated m 6 A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis. Cell death & disease 13 (11) (2022)
Yufei Wang, Yiyang Liu, Bixiang Zhang, Xiao-Ping Chen, Bixiang Zhang
The roles of osteoprotegerin in cancer, far beyond a bone player. Cell death discovery 8 (1) (2022)
Mingyang Ma, Shuyao Hua, Xiangde Min, Liang Wang, Jun Li, Ping Wu, Huifang Liang, Bixiang Zhang, Xiao-Ping Chen, Shuai Xiang
p53 positively regulates the proliferation of hepatic progenitor cells promoted by laminin-521. Signal transduction and targeted therapy 7 (1) (2022)
Hongwei Zhang, Zhibin Liao, Weijian Wang, Yachong Liu, He Zhu, Hui-Fang Liang, Bixiang Zhang, Xiao-Ping Chen
A micropeptide JunBP regulated by TGF-β promotes hepatocellular carcinoma metastasis. Oncogene (2022)
Chao Wang, Pingcuo Ciren, Awang Danzeng, Yong Li, Cheng-Long Zeng, Zhi-Wei Zhang, Zhi-Yong Huang, Yi-Fa Chen, Wan-Guang Zhang, Bi-Xiang Zhang, Bin-Hao Zhang, Xiao-Ping Chen
Anatomical Resection Improved the Outcome of Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis of a Retrospective Cohort. Journal of oncology 2022 (2022)
Junnan Liang, Ganxun Li, Jingyu Liao, Zhao Huang, Jingyuan Wen, Yu Wang, Zeyu Chen, Guangzhen Cai, Weiqi Xu, Zeyang Ding, Hui-Fang Liang, Pran K Datta, Liang Chu, Xiao-Ping Chen, Bixiang Zhang
Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation. Cell death and differentiation 29 (5) (2022)
Danfei Liu, Tongyue Zhang, Xiao-Ping Chen, Bixiang Zhang, Yijun Wang, Meng Xie, Xiaoyu Ji, Mengyu Sun, Wenjie Huang, Limin Xia
ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY. Cell death & disease 12 (12) (2021)
Danfei Liu, Tongyue Zhang, Xiao-Ping Chen, Bixiang Zhang, Yijun Wang, Meng Xie, Xiaoyu Ji, Mengyu Sun, Wenjie Huang, Limin Xia
Correction to: ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY. Cell death & disease 13 (1) (2021)